BIOCRYST PHARMACEUTICALS INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Return On Assets for the quarter ending September 30, 2024 was -25.4 %, a 43.2% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2023 was -43.6 %, a 5.37% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2022 was -46 %, a 11.5% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2021 was -52 %, a 38.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -25.4 +19.3 +43.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29.5 +15.7 +34.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -41 +1.57 +3.69% Jan 1, 2024 Mar 31, 2024
Q4 2023 -43.6 +2.47 +5.37% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44.8 -9.35 -26.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -45.2 -0.88 -1.99% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.5 +4.26 +9.11% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46 +5.97 +11.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -35.4 +42.7 +54.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -44.3 +35.5 +44.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -46.8 +36.2 +43.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -52 +32.8 +38.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.1 -6.94 -9.76% Jul 1, 2021 Sep 30, 2021
Q2 2021 -79.8 -4.37 -5.79% Apr 1, 2021 Jun 30, 2021
Q1 2021 -83 +6.06 +6.81% Jan 1, 2021 Mar 31, 2021
Q4 2020 -84.8 -1.76 -2.12% Oct 1, 2020 Dec 31, 2020
Q3 2020 -71.1 +36.7 +34% Jul 1, 2020 Sep 30, 2020
Q2 2020 -75.5 +12.2 +13.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -89 -17.3 -24.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -83.1 -16.4 -24.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -108 -49.3 -84.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -87.6 -39.9 -83.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -71.7 -23.3 -48.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -66.7 -23.8 -55.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -58.5 -19.8 -51.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -47.7 -3.26 -7.34% Apr 1, 2018 Jun 30, 2018
Q1 2018 -48.4 -1.09 -2.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -42.9 +17.3 +28.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -38.7 +30.3 +43.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -44.4 +20 +31% Apr 1, 2017 Jun 30, 2017
Q1 2017 -47.4 -7.93 -20.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -60.2 -28.4 -89.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -69 -42.7 -162% Jul 1, 2016 Sep 30, 2016
Q2 2016 -64.4 -42.3 -191% Apr 1, 2016 Jun 30, 2016
Q1 2016 -39.4 -2.62 -7.12% Jan 1, 2016 Mar 31, 2016
Q4 2015 -31.8 +7.56 +19.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -26.3 +15.7 +37.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -22.1 +31 +58.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -36.8 +40.3 +52.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -39.4 +24.4 +38.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -42 +30.4 +42% Jul 1, 2014 Sep 30, 2014
Q2 2014 -53.2 +18.7 +26% Apr 1, 2014 Jun 30, 2014
Q1 2014 -77.1 -15.8 -25.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -63.8 -7.5 -13.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -72.4 -17.9 -32.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -71.9 -16.3 -29.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -61.4 -6.33 -11.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -56.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -54.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -55.6 Apr 1, 2012 Jun 30, 2012
Q1 2012 -55 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.